Stephen C. Textor

Active 1982–2022

98
Papers
19,397
Citations
79
h-index
98
i10-index

Citations

Citations per year for Stephen C. Textor1983: 2 citations1984: 3 citations1985: 1 citations1986: 7 citations1987: 3 citations1988: 5 citations1989: 2 citations1990: 7 citations1991: 6 citations1992: 8 citations1993: 9 citations1994: 11 citations1995: 11 citations1996: 15 citations1997: 15 citations1998: 30 citations1999: 31 citations2000: 41 citations2001: 44 citations2002: 57 citations2003: 43 citations2004: 73 citations2005: 91 citations2006: 95 citations2007: 91 citations2008: 97 citations2009: 119 citations2010: 110 citations2011: 138 citations2012: 125 citations2013: 145 citations2014: 112 citations2015: 78 citations2016: 88 citations2017: 119 citations2018: 76 citations2019: 389 citations2020: 497 citations2021: 469 citations2022: 400 citations2023: 318 citations2024: 486 citations2025: 247 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,852 citing papers, 31.5% of this breakdownChina: 545 citing papers, 9.3% of this breakdownUnited Kingdom: 412 citing papers, 7% of this breakdownItaly: 294 citing papers, 5% of this breakdownGermany: 254 citing papers, 4.3% of this breakdownFrance: 193 citing papers, 3.3% of this breakdownCanada: 186 citing papers, 3.2% of this breakdownSpain: 165 citing papers, 2.8% of this breakdownJapan: 163 citing papers, 2.8% of this breakdownNetherlands: 148 citing papers, 2.5% of this breakdownAustralia: 134 citing papers, 2.3% of this breakdownSwitzerland: 112 citing papers, 1.9% of this breakdown
0%31.5%Other 24.1%

Fields

  • Medicine80.7%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Immunology and Microbiology2.9%
  • Neuroscience1.5%
  • Nursing0.9%
  • Health Professions0.5%
  • Other2%

Topics

  • Blood Pressure and Hypertension Studies4.6%
  • Chronic Kidney Disease and Diabetes4.3%
  • Renal and Vascular Pathologies3.9%
  • Telomeres, Telomerase, and Senescence3.8%
  • Acute Kidney Injury Research3.7%
  • Renal Transplantation Outcomes and Treatments3.6%
  • Other76.1%

Coauthors

All papers

Open in search
  1. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yi Zhu, Tamar Tchkonia, James L. Kirkland - EBioMedicine 2019 cited by 1,286

  2. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , , , , , , , , - Hypertension 2018 cited by 1,074

  3. Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy

    Authors: , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2021 cited by 103

  4. Resistant Hypertension: Diagnosis, Evaluation, and Treatment

    Authors: , , , , , , , , , , , , , - Circulation 2008 cited by 2,238

  5. The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults

    Authors: , , , , , , , - Annals of Internal Medicine 2010 cited by 498

  6. Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidney

    Authors: , , , , , , , , , , , , , , , - Scientific Reports 2018 cited by 114

  7. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , - Circulation 2002 cited by 1,723

  8. Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , - Hypertension 2022 cited by 62

  9. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis

    Authors: , , , , , , , , , - Circulation Cardiovascular Interventions 2017 cited by 120

  10. Renal-Artery Stenosis

    Authors: , - New England Journal of Medicine 2001 cited by 1,065

  11. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation

    Authors: , , , , , , - Kidney International 2005 cited by 392

  12. The role of the kidney in regulating arterial blood pressure

    Authors: , - Nature Reviews Nephrology 2012 cited by 162

  13. Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy

    Authors: , , , , , , , , , , , , , , , , , , , - BMJ Open Diabetes Research & Care 2019 cited by 64

  14. Increased cellular senescence in the murine and human stenotic kidney: Effect of mesenchymal stem cells

    Authors: , , , , , , , , , , - Journal of Cellular Physiology 2020 cited by 47

  15. Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review

    Authors: , , , , , , , , , - Nephrology Dialysis Transplantation 2018 cited by 142

  16. In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure

    Authors: , , , , , , , , , , , , - Kidney International 2019 cited by 102

  17. Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference

    Authors: , , , , , , , , , , , , - American Journal of Kidney Diseases 2021 cited by 74

  18. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jolanta Małyszko, Patrick B. Mark, Marius Miglinas, Patrick Murray, Chris Reid, Paul J. Rochon, Josiah Ruturi, Athanasios Saratzis, Mark J. Sarnak, Cathy M. Shanahan, Laura Solá, Ulf Teichgräber, Stephen C. Textor, Ḱazunori Toyoda, Angela Yee‐Moon Wang, Chris X. Wong - Kidney International 2021 cited by 60

  19. Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease

    Authors: , , , , , , , , , , , - Journal of the American Society of Nephrology 2017 cited by 168

  20. Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure

    Authors: , , , , , , - Journal of the Autonomic Nervous System 1994 cited by 105

  21. Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David B. Allison, Stephanie Dickinson, Keisuke Ejima, Elizabeth J. Atkinson, Marc E. Lenburg, Yi Zhu, Tamar Tchkonia, James L. Kirkland - EBioMedicine 2020 cited by 58

  22. Senescent Kidney Cells in Hypertensive Patients Release Urinary Extracellular Vesicles

    Authors: , , , , , , , , - Journal of the American Heart Association 2019 cited by 47

  23. Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal Repair

    Authors: , , , , , , , , , , , , , , , , , , , , - Diabetes 2021 cited by 33

  24. Adipose Tissue‐Derived Mesenchymal Stem Cells Improve Revascularization Outcomes to Restore Renal Function in Swine Atherosclerotic Renal Artery Stenosis

    Authors: , , , , , , , , - Stem Cells 2012 cited by 261